Novasep to invest in purification-based manufacturing; opens China plant
Novasep says it may invest in active pharmaceutical ingredients (API) bioproduction and purification technology citing growing industry demand.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs